Patients with a known BMPR2 mutation, scleroderma, and portal<unk>  undergoing evaluation for liver transplantation should receive periodic screening for<unk><unk>  (PH) through echocardiography.
Pulmonary hypertension screening
Hypertrophic cardiomyopathy screening
Diabetic nephropathy screening
Peripheral arterial disease screening
Abdominal aortic aneurysm screening
Cyanosis screening
Carotid artery stenosis screening
Chronic renal failure screening